Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The news of the collaboration was a nice uptick, and vote of confidence
No, I was at work then, but it was to brief anyway.
I wake up at 3am Mountain time for work, so sometimes I'll see news on something besides Tesla and Apple,, lol.
Around 2.70 for a few minutes.
Even a jump to $5 would please me.
Two catalysts this month, be patient and cross your fingers folks.
That is fascinating.
And people think you can't make money on renewables and environmentally friendly industries.
Beats the heck out of coal and oil stocks.
Good day on an overall bad day.
News?
Nice close today.
Recommended on CNBC today.
Looks like Terry Chrisomalis should be followed.
I'd love that.
Welcome to biotech.
Set dates are rare, they always give us a window of a few months when reporting results.
Exactly.
And now we have a 18% (so far) gain on no news today.
B. Riley analyst Mayank Mamtani says Acasti Pharma's (NASDAQ:ACST) 24% pullback yesterday was "unwarranted" as the delay in CaPre drug data is likely "inconsequential" to the anticipated study results.
Yesterday, Acasti announced it will now report top-line results for the Trilogy 1 Phase 3 trial in January 2020 due to an unexpected delay in data processing.
Mamtani also notes ACST's "incrementally improved balance sheet," which limits the "post-data financing overhang."
B. Riley maintains a Buy rating and $8 PT on ACST. The company has a Very Bullish average Sell Side rating.
Short Squeeze?
Absolutely.
And he is correct.
Anybody who says to buy, or sell without giving a reason is a troll.
When you message me I return.
Stop messaging me.
I'll be back in three months.
Why isn't it garbage?
My fees?
You are the Pumper, not me.
I was on in a few years ago because of Pumpers.
Never again,,
Damn!
I sold just above $15.
I didn't expect this to keep going.
Oh well, on others Iv seen massive sell offs after big spikes on positive news.
Eat cheese ;)
Just kidding.
Compare since you posted this.
They have had a 'plan' for the past five years.
Imagine if ones money had been put into even a steady SP500 darling for those five years?
I agree, although the lack of interest is puzzling.
Is Vid on StockTwits, or Seeking Al?
Now he's on.
Watch it,, just in case.
Congratulations everybody.
Oh, Hell yes!
The little stock that could, can.
Amen.
ACST is on the NASDAQ exchange.
Phase 3 results coming up.
GLTA.
December 3rd is our big day.
I sold half after hours in case if a profit taking sell off.
I may buy back in if this dips.
YEEEHAWWW!!!!
The company announces positive topline data from its pivotal phase III ADVOCATE trial for avacopan.
The test achieved both primary endpoints of clinical remission at weeks 26 and 52 with statistical superiority of avacopan over standard of care (SOC) at 52 weeks.
Other notes: Significantly reduced glucocorticoid toxicity, significantly improved kidney function compared to glucocorticoid-containing SOC, improved health-related quality of life measures compared to SOC
A conference call is just underway.
CCXI +265.4%
Carrot and stick, or chasing the dragon.
I bailed on $GEQU slash $ARGQ five years ago.
Some of you have been here much longer than that.
Why?